| Accession | PRJCA023487 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Title | JZJC: A Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab | ||||||||
| Relevance | Medical | ||||||||
| Data types | Genome sequencing | ||||||||
| Organisms | Homo sapiens | ||||||||
| Description | Comparing Selpercatinib to Platinum Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer | ||||||||
| Sample scope | Multiisolate | ||||||||
| Release date | 2024-02-06 | ||||||||
| Grants |
|
||||||||
| Submitter | ling zhang (shfkgcp@163.com) | ||||||||
| Organization | shanghai pulmonary hospital | ||||||||
| Submission date | 2024-02-06 |
| Resource name | Description |
|---|